Total Funding
67
17
Total FundingDebt Financing raised
Growth Score
-6 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
740977
Insception Biosciences is a cord blood program in Canada.
- Robert Casper: Medical Director & FounderPast Role: Insception Biosciences, Founding Member
Richard Lockie: Chairman & CEO
About the Company
Insception is the largest cord blood program in Canada with over 39,000 cord blood units banked. Insception is owned by Argosy Partners, Mount Sinai Hospital, management and its scientific founders. By partnering with leading Canadian medical facilities such as Toronto's Mount Sinai and the Scarborough Hospitals, Insception continues to work
closely with Canada's leading healthcare providers. The Insception Cord Blood Program is able to provide every Canadian family with security, state of the art processing and storage, financial stability and long term professional governance.
